4601 - 4650 of 8808 Results
Title
Year
-
OPENTitle: Safety, Efficacy, And Pharmacokinetics of Argx-117 in Adults With Multifocal Motor Neuropathy: A Global, Multicenter, Placebo Controlled Phase 2 Study (Arda)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903320.23411.f9Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S40.full.pdfCitation Count: 3
-
RESTRICTEDTitle: Understanding Correlation of Electroclinical Findings With Functional and Neuropsychiatric Outcomes in Patients with LGI1-EncephalitisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903424.19914.85Citation Count: 0
-
OPENTitle: An Observational Study on the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis and Other Autoimmune Neurological Disorders Treated With Anti-CD20 TherapiesJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903428.98962.0aBest OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S52.full.pdfCitation Count: 1
-
OPENTitle: Quality of Life for Patients With Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 22Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000200741Citation Count: 3
-
OPENTitle: What Is the Role of Dopamine Transporter Imaging in Parkinson Prevention Clinical Trials?Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 7_Supplement_1Start Page: 61End Page: 67Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000200786Best OA location URL: https://n.neurology.org/content/neurology/99/7_Supplement_1/61.full.pdfCitation Count: 18
-
OPENTitle: Lifestyle Interventions for the Prevention of Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 7_Supplement_1Start Page: 42End Page: 51Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000200787Best OA location URL: https://n.neurology.org/content/neurology/99/7_Supplement_1/42.full.pdfCitation Count: 44
-
RESTRICTEDTitle: 2022 Emerging Science AbstractsJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000200917Citation Count: 1
-
RESTRICTEDTitle: Assessment of Bioenergetic Deficits in Patients With Parkinson Disease and Progressive Supranuclear Palsy Using 31 P-MRSIJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 24Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000201288Citation Count: 8
-
RESTRICTEDTitle: Association of Early Weight Change With Cognitive Decline in Patients With Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 100Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000201404Citation Count: 9
-
RESTRICTEDTitle: Progressive Supranuclear Palsy Syndrome Associated With a Novel TauopathyJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 24Start Page: 1094End Page: 1098Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000201485Citation Count: 10
-
RESTRICTEDTitle: Quantitative determination of LY‐404,039, a metabotropic glutamate 2/3 receptor agonist, in rat plasma using chemical derivatization and HPLC–MRM/MSJournal Name: Biomedical ChromatographyPublisher: WileyVol: 36Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/bmc.5423Citation Count: 2
-
OPENTitle: Impaired bed mobility in prediagnostic and de novo Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 98Issue #:Start Page: 47End Page: 52Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.04.007Citation Count: 4
-
RESTRICTEDTitle: Disrupted rich-club organization of brain structural networks in Parkinson’s diseaseJournal Name: Brain Structure and FunctionPublisher: Springer Science and Business Media LLCVol: 226Issue #: 7Start Page: 2205End Page: 2217Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00429-021-02319-3Citation Count: 19
-
OPENTitle: Comprehensive assessment of PINK1 variants in Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 91Issue #:Start Page: 168.e1End Page: 168.e5Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.03.003Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7236133Citation Count: 45
-
OPENTitle: Non-reference genome transposable elements (TEs) have a significant impact on the progression of the Parkinson’s diseaseJournal Name: Experimental Biology and MedicinePublisher: Frontiers Media SAVol: 247Issue #: 18Start Page: 1680End Page: 1690Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/15353702221117147Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9597212Citation Count: 12
- The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease2019OPENTitle: The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 4Start Page: 460End Page: 468Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27614Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6467788Citation Count: 78
-
OPENTitle: Cholinergic Basal Forebrain Volumes Predict Gait Decline in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 3Start Page: 611End Page: 621Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.28453Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28453Citation Count: 40
-
RESTRICTEDTitle: Levodopa-induced dyskinesia is preceded by increased levels of anxiety and motor impairment in Parkinson’s disease patientsJournal Name: International Journal of NeurosciencePublisher: Informa UK LimitedVol: 133Issue #: 12Start Page: 1319End Page: 1325Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/00207454.2022.2079501Citation Count: 5
-
RESTRICTEDTitle: Longitudinal Mediating Effect of Depression on the Relationship between Excessive Daytime Sleepiness and Activities of Daily Living in Parkinson’s DiseaseJournal Name: Clinical GerontologistPublisher: Informa UK LimitedVol: 47Issue #: 3Start Page: 426End Page: 435Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/07317115.2022.2111014Citation Count: 7
-
RESTRICTEDTitle: Preferences for Communication About End‐of‐Life Care in Atypical ParkinsonismJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 9Start Page: 2116End Page: 2125Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28633Citation Count: 13
- Editor's Note2022RESTRICTEDTitle: Editor's NoteJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1329End Page: 1329Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29149Citation Count: 0
-
RESTRICTEDTitle: Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations?Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1779End Page: 1781Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29132Citation Count: 11
-
OPENTitle: Multi-Class Classifier in Parkinson’s Disease Using an Evolutionary Multi-Objective Optimization AlgorithmJournal Name: Applied SciencesPublisher: MDPI AGVol: 12Issue #: 6Start Page: 3048End Page: 3048Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/app12063048Best OA location URL: https://www.mdpi.com/2076-3417/12/6/3048/pdf?version=1647497233Citation Count: 7
-
OPENTitle: Epidemiology and economic burden of Huntington’s disease: a Canadian provincial public health system perspectiveJournal Name: Journal of Medical EconomicsPublisher: Informa UK LimitedVol: 25Issue #: 1Start Page: 212End Page: 219Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/13696998.2022.2033493Best OA location URL: https://doi.org/10.1080/13696998.2022.2033493Citation Count: 18
-
RESTRICTEDTitle: Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson’s diseaseJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 22Issue #: 6Start Page: 489End Page: 498Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14737175.2022.2091436Citation Count: 15
-
RESTRICTEDTitle: Structural and Textual Information Fusion for Symptom and Disease Representation LearningJournal Name: IEEE Transactions on Knowledge and Data EngineeringPublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 34Issue #: 9Start Page: 4468End Page: 4483Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1109/tkde.2020.3039469Citation Count: 5
-
RESTRICTEDTitle: Evaluation of the Dementia Apraxia Test in Parkinson’s Disease PatientsJournal Name: Dementia and Geriatric Cognitive DisordersPublisher: S. Karger AGVol: 51Issue #: 3Start Page: 271End Page: 278Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1159/000525618Citation Count: 2
-
RESTRICTEDTitle: Hippocampal Functional Connectivity in Parkinson’s DiseaseJournal Name: Neurodegenerative DiseasesPublisher: S. Karger AGVol: 22Issue #: 1Start Page: 29End Page: 33Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1159/000526377Citation Count: 6
-
OPENTitle: At a Glance: An Update on Neuroimaging and Retinal Imaging in Alzheimer's Disease and Related ResearchJournal Name: The Journal of Prevention of Alzheimer's DiseasePublisher: Elsevier BVVol: 9Issue #: 1Start Page: 1End Page: 10Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.14283/jpad.2022.7Best OA location URL: https://link.springer.com/content/pdf/10.14283/jpad.2022.7.pdfCitation Count: 1
-
OPENTitle: Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severityJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-015-0185-3Best OA location URL: https://actaneurocomms.biomedcentral.com/counter/pdf/10.1186/s40478-015-0185-3Citation Count: 82
-
OPENTitle: Deep brain stimulation induced normalization of the human functional connectome in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 142Issue #: 10Start Page: 3129End Page: 3143Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awz239Best OA location URL: https://academic.oup.com/brain/article-pdf/142/10/3129/30063714/awz239.pdfCitation Count: 155
-
OPENTitle: Comparing machine learning and deep learning models to predict cognition progression in Parkinson's diseaseJournal Name: Clinical and Translational SciencePublisher: WileyVol: 17Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/cts.70066Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.70066Citation Count: 1
-
OPENTitle: The R1441C-Lrrk2 mutation induces myeloid immune cell exhaustion in an age- and sex-dependent manner in miceJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 16Issue #: 772Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.adl1535Best OA location URL: https://www.science.org/doi/pdf/10.1126/scitranslmed.adl1535?download=trueCitation Count: 5
-
RESTRICTEDTitle: The many genomes of Parkinson's diseaseJournal Name: International Review of NeurobiologyPublisher: ElsevierVol:Issue #:Start Page: 59End Page: 80Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/bs.irn.2022.07.007Citation Count: 3
-
OPENTitle: Reduced and Delayed Cerebrovascular Reactivity in Patients with Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 7Start Page: 1262End Page: 1272Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29429Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29429Citation Count: 14
-
OPENTitle: Mutation of the ALS-/FTD-Associated RNA-Binding Protein FUS Affects Axonal DevelopmentJournal Name: The Journal of NeurosciencePublisher: Society for NeuroscienceVol: 44Issue #: 27Start Page: e2148232024End Page: e2148232024Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-sa, cc-by-nc-sa, cc-by-nc-saDOI - Digital Object Identifier: 10.1523/jneurosci.2148-23.2024Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7616130Citation Count: 1
-
OPENTitle: Functional efficacy of the MAO-B inhibitor safinamide in murine substantia nigra pars compacta dopaminergic neurons in vitro: A comparative study with tranylcypromineJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 128Issue #:Start Page: 107158End Page: 107158Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107158Best OA location URL: https://www.prd-journal.com/article/S1353-8020(24)01170-2/pdfCitation Count: 2
-
OPENTitle: The GBA variant E326K is associated with alpha-synuclein aggregation and lipid droplet accumulation in human cell linesJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1093/hmg/ddac233Best OA location URL: https://academic.oup.com/hmg/article-pdf/32/5/773/49283269/ddac233.pdfCitation Count: 11
-
OPENTitle: Programmed autophagy prevents excess organelle baggage during neurogenesisJournal Name: Molecular CellPublisher: Elsevier BVVol: 81Issue #: 24Start Page: 4960End Page: 4961Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.molcel.2021.11.034Citation Count: 0
-
OPENTitle: Viral overexpression of human alpha-synuclein in mouse substantia nigra dopamine neurons results in hyperdopaminergia but no neurodegenerationJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 382Issue #:Start Page: 114959End Page: 114959Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.expneurol.2024.114959Best OA location URL: https://doi.org/10.1016/j.expneurol.2024.114959Citation Count: 4
-
OPENTitle: A Double‐Blind, Randomized, Placebo‐Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 8Start Page: 1493End Page: 1502Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29450Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29450Citation Count: 25
-
RESTRICTEDTitle: Integrating Multimorbidity into a Whole-Body Understanding of Disease Using Spatial GenomicsJournal Name: Results and Problems in Cell DifferentiationPublisher: Springer International PublishingVol:Issue #:Start Page: 157End Page: 187Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/978-3-031-06573-6_5Citation Count: 0
-
OPENTitle: Ethnoracial differences for caregiving burden in Parkinson’s diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 118Issue #:Start Page: 105927End Page: 105927Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105927Best OA location URL: http://www.prd-journal.com/article/S1353802023010064/pdfCitation Count: 1
-
OPENTitle: Peripheral blood immune cells from individuals with Parkinson's disease or inflammatory bowel disease share deficits in iron storage and transport that are modulated by non-steroidal anti-inflammatory drugsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 207Issue #:Start Page: 106794End Page: 106794Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2025.106794Best OA location URL: https://doi.org/10.1016/j.nbd.2025.106794Citation Count: 1
-
RESTRICTEDTitle: The Parkinson’s disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neuronsJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 19Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-024-00779-9Best OA location URL: https://link.springer.com/content/pdf/10.1186/s13024-024-00779-9.pdfCitation Count: 9
-
OPENTitle: Long‐Read Sequencing Resolves a Complex Structural Variant in PRKN Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 12Start Page: 2249End Page: 2257Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29610Best OA location URL: https://pub.dzne.de/search?p=id:%22DZNE-2024-00014%22Citation Count: 17
-
OPENTitle: Functional Impairment in Miro Degradation and Mitophagy Is a Shared Feature in Familial and Sporadic Parkinson’s DiseaseJournal Name: Cell Stem CellPublisher: Elsevier BVVol: 19Issue #: 6Start Page: 709End Page: 724Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.stem.2016.08.002Best OA location URL: http://doi.org/10.1016/j.stem.2016.08.002Citation Count: 429
-
OPENTitle: Connectivity Predicts deep brain stimulation outcome in Parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 82Issue #: 1Start Page: 67End Page: 78Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.24974Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5880678Citation Count: 609
-
OPENTitle: A comprehensive analysis of SNCA‐related genetic risk in sporadic parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 84Issue #: 1Start Page: 117End Page: 129Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.25274Citation Count: 60
-
OPENTitle: The integrated stress response pathway and neuromodulator signaling in the brain: lessons learned from dystoniaJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 134Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1172/jci177833Best OA location URL: https://doi.org/10.1172/jci177833Citation Count: 10